<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Lipid metabolites is_biomarker_for Colorectal Cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Lipid metabolites</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Colorectal Cancer</strong>
</div>
<div class="entity-id">UNKNOWN:lipid metabolites &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: Curated (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 148.48<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.5 (Curated) &times; log&#8322;(1+1) = 0.50<br>Incoming citations: 61 &rarr; score 148.48</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="Curated"></span><span>Curated</span><a href="https://doi.org/10.18632/oncotarget.16727">10.18632/oncotarget.16727</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 61 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:54px"></span><span>20</span><span class="cite-subtotal">&middot; +29.58</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycerophospholipids — decreases → colorectal cancer liver metastasis (tumor-bearing liver)</span><span class="cite-claim-weight">+0.79</span><a href="../claim/8048666659750fb3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycerophospholipids (3 metabolites, increased risk group) — increases → colorectal cancer risk</span><span class="cite-claim-weight">+0.50</span><a href="../claim/3edb9a88379dc447.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">panel of 9 independently associated metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/62d946c10b2c5b02.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycerophospholipids — causes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/95b626a1b17019f3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SWATHtoMRM method — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6a5cfbad44c61df6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">17 validated metabolite biomarkers — predicts → colorectal cancer prognosis after tumor resection</span><span class="cite-claim-weight">+0.50</span><a href="../claim/c254140a94088a9b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.79</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TTD metabolite panel (8 metabolites) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/244e9f1f256e747e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/25bc564792710f83.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 34:0 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/6755aed6969a335f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 37:1 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5461904f66dd04a0.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerol TG 56:4 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.50</span><a href="../claim/41e53c43b7a04e7e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — predicts → 5-year Overall Survival in female CRC patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/2f6b8b95246fd19c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Lysophospholipids — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+10.00</span><a href="../claim/b50eeb9d6580aa37.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">12-biomarker urinary metabolite panel — distinguishes → colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/3cf631cb370ed16a.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:3px"></span><span>1</span><span class="cite-subtotal">&middot; +12.68</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">asparagine synthetase (ASNS) — increases → asparagine</span><span class="cite-claim-weight">+12.68</span><a href="../claim/cbbe665fd9d7a715.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>37</span><span class="cite-subtotal">&middot; +105.31</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">glycine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/3ad853dd9decc127.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">+5.57</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+7.20</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">+1.55</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">blood metabolites (35 significant) — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1a39df3f9510434a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">20 potential metabolite biomarkers panel — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/33fe4093f005b045.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">survival risk score (metabolite biomarkers) — predicts → overall survival</span><span class="cite-claim-weight">+0.60</span><a href="../claim/59a7e5675693b138.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">TTD metabolites in plasma — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/1079d4ecf1f2ac14.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tryptophan — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+1.39</span><a href="../claim/a42864072a5c69c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/4013d9365dfef12a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — is_biomarker_for → Right-sided colon cancer in women</span><span class="cite-claim-weight">+19.02</span><a href="../claim/16c02890060bd0fd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">DNA methylation — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d1fe89a5c42232d1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">microRNA — is_biomarker_for → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/f25cb0e88b0f6688.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">fecal hemoglobin — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/b7e485cb03d43c01.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ed1d7e2112a84a62.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — predicts → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/028a1d5bfb7f13f4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 34:0 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bd2b1c00049c4695.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine PC 37:1 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/0d3ac63cb558fadd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine PE 34:2 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6dcbfda2c1089a5e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Triacylglycerol TG 56:4 — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/dec5c4119bcf8d8a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Serine — distinguishes → 5-year Overall Survival by sex in Colorectal Cancer</span><span class="cite-claim-weight">+19.02</span><a href="../claim/4421b19a889d7968.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Asparagine — correlates_with → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/c6bfb7fbe92da16b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">Polyamines — predicts → Poor prognosis in female Colorectal Cancer patients</span><span class="cite-claim-weight">+12.00</span><a href="../claim/6dc001440b4efbb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">chenodeoxycholic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/25ee19050e11a581.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">vanillic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6b88531843cb320e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">adenosine monophosphate — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+4.80</span><a href="../claim/2ef1ab352bde0f48.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">glycolic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/ca40739fbc59d8e6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">histidine — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/4eaf76a404e49857.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">azelaic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8bd1b8a096df67ba.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">hydroxypropionic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/a2d947a83c392fed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">3,4-dihydroxymandelic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/083ca1603bdf7fb3.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">4-hydroxybenzoic acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/6392e7363ddfadd7.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">oxoglutaric acid — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/378410604675a5aa.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">homocitrulline — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/9e24739a11507ad8.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:8px"></span><span>3</span><span class="cite-subtotal">&middot; +0.90</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">survival risk score (metabolite biomarkers) — predicts → progression-free survival</span><span class="cite-claim-weight">+0.30</span><a href="../claim/7d2632421e928b99.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine PE 34:2 — correlates_with → Bisphenol A</span><span class="cite-claim-weight">+0.30</span><a href="../claim/467cb1cf8f538733.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Bisphenol A — causes → Colorectal Cancer</span><span class="cite-claim-weight">+0.30</span><a href="../claim/7d3063bbbc490a47.html">view &rarr;</a></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>8dc61ea80945ac04</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/UNKNOWN:lipid metabolites">UNKNOWN:lipid metabolites</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
